Internal Medicine Alert – July 15, 2020
July 15, 2020
View Issues
-
Two Possible Mechanisms of Disease in COVID-19
COVID-19 infection may be associated with an increased risk of blood clotting and related thrombotic events, but there are insufficient data to support indiscriminately discontinuing medications that play a critical role in the management of chronic cardiovascular disease.
-
Early Data on Remdesivir for Severe COVID-19: A Promising Start?
In this group of patients hospitalized with severe COVID-19, most of whom required invasive ventilation, 68% showed clinical improvement after treatment with remdesivir on a compassionate-use basis.
-
MUCH Ado About WUCH
In a long-term, fixed-drug therapy of hypertension study, masked uncontrolled and white coat uncontrolled hypertension exhibited poor reproducibility over four years.
-
Cloth Masks — Just for Looks?
How effective are homemade fabric masks many are using to protect others from COVID-19 transmission?
-
Elagolix, Estradiol, and Norethindrone Acetate Capsules (Oriahnn)
Elagolix-EN should be prescribed to manage heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.
-
Group Beating from Wenckebach?
The two rhythm strips in the figure were recorded just a few minutes apart. There is group beating. Is the rhythm the result of atrioventricular (AV) Wenckebach (second degree AV block, Mobitz Type I)?